- Home
- MNMD vs AHG Comparison
MNMD vs AHG Comparison
Compare MNMD & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNMD
- AHG
- Stock Information
- Founded
- MNMD 2019
- AHG 2013
- Country
- MNMD United States
- AHG China
- Employees
- MNMD N/A
- AHG N/A
- Industry
- MNMD Pharmaceuticals and Biotechnology
- AHG Business Services
- Sector
- MNMD Health Care
- AHG Consumer Discretionary
- Exchange
- MNMD Nasdaq
- AHG Nasdaq
- Market Cap
- MNMD 960.2M
- AHG 878.7M
- IPO Year
- MNMD N/A
- AHG N/A
- Fundamental
- Price
- MNMD $11.01
- AHG $1.62
- Analyst Decision
- MNMD Strong Buy
- AHG
- Analyst Count
- MNMD 7
- AHG 0
- Target Price
- MNMD $26.71
- AHG N/A
- AVG Volume (30 Days)
- MNMD 2.3M
- AHG 18.1K
- Earning Date
- MNMD 11-06-2025
- AHG 09-12-2025
- Dividend Yield
- MNMD N/A
- AHG N/A
- EPS Growth
- MNMD N/A
- AHG N/A
- EPS
- MNMD N/A
- AHG N/A
- Revenue
- MNMD N/A
- AHG $14,777,798.00
- Revenue This Year
- MNMD N/A
- AHG N/A
- Revenue Next Year
- MNMD N/A
- AHG N/A
- P/E Ratio
- MNMD N/A
- AHG N/A
- Revenue Growth
- MNMD N/A
- AHG 512.09
- 52 Week Low
- MNMD $4.70
- AHG $0.74
- 52 Week High
- MNMD $14.43
- AHG $2.35
- Technical
- Relative Strength Index (RSI)
- MNMD 41.39
- AHG 47.44
- Support Level
- MNMD $12.60
- AHG $1.59
- Resistance Level
- MNMD $14.43
- AHG $1.82
- Average True Range (ATR)
- MNMD 0.84
- AHG 0.10
- MACD
- MNMD -0.30
- AHG 0.01
- Stochastic Oscillator
- MNMD 11.52
- AHG 26.25
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
About AHG Akso Health Group ADS
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.